Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 112

Results For "PPL"

2450 News Found

Blue Jet Healthcare gets SEBI nod for IPO
News | January 20, 2023

Blue Jet Healthcare gets SEBI nod for IPO

The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.


Cheplapharm selects Generis’ CARA Life Sciences platform to unify their clinical processes
News | January 20, 2023

Cheplapharm selects Generis’ CARA Life Sciences platform to unify their clinical processes

Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes


AI to drive digital mammography equipment market in South Korea during 2015-2030: GlobalData
Medical Device | January 18, 2023

AI to drive digital mammography equipment market in South Korea during 2015-2030: GlobalData

AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”


Panacea Biotec donates 125,000 doses of Easyfive-TT to Cuba
News | January 18, 2023

Panacea Biotec donates 125,000 doses of Easyfive-TT to Cuba

This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba


Lonza collaborates Cristal Therapeutics and McSAF to expand Bioconjugates offering
News | January 18, 2023

Lonza collaborates Cristal Therapeutics and McSAF to expand Bioconjugates offering

Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates


Lupin receives tentative approval from USFDA for Dolutegravir and Rilpivirine Tablets
Drug Approval | January 17, 2023

Lupin receives tentative approval from USFDA for Dolutegravir and Rilpivirine Tablets

Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of US $666 million in the US (IQVIA MAT September 2022)


1st G20 Health Working Group Meeting to commence on 18th January at Thiruvananthapuram
Policy | January 17, 2023

1st G20 Health Working Group Meeting to commence on 18th January at Thiruvananthapuram

India's G20 Presidency will focus on three main priorities: Health Emergencies Prevention, Preparedness and Response (One Health & AMR); Access and Availability to Affordable Medical Countermeasures (Vaccines, Therapeutics, and Diagnostics); and Digital Health


USFDA inspections gather pace; Indian pharma companies equipped to handle disruptions
Drug Approval | January 17, 2023

USFDA inspections gather pace; Indian pharma companies equipped to handle disruptions

The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22


USFDA conducts PAI and GMP inspection of Piramal Pharma's Sellersville facility
Drug Approval | January 16, 2023

USFDA conducts PAI and GMP inspection of Piramal Pharma's Sellersville facility

The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations


China, South Korea, and India driving innovation in medical robotics in APAC, says GlobalData
News | January 16, 2023

China, South Korea, and India driving innovation in medical robotics in APAC, says GlobalData

APAC to see a reduction in imported surgical robotics